http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2908837-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d4cb68e87aef71dbc25db0f6b3334d http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f4d86235703b3e2a1cb10b98722d80d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate | 2013-10-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a59bb219a87112ff1a976af69bbbdd1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382558203fd5140fc230f50f283c1318 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3ec53078f6e567605a2b79e170d966 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b67ea7410d9d23ee6c45fb9dd18c0a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57d29d39e920e2f3c9922fe93dee51b0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1aff6933ffa524abb1a39a8003c22f9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22f00cb1b88ce721c26335db1a7ddc63 |
| publicationDate | 2015-08-26^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2908837-A1 |
| titleOfInvention | Compositions and methods for drug delivery |
| abstract | The invention relates to compositions and methods suitable for delivering molecules to a mammal. The invention particularly relates to peptide derivatives (peptides and pseudo- peptides), dimers or multimers thereof, and to their use as vectors for molecules of interest. The invention also relates to conjugates containing a peptide derivative of the invention or a dimer or multimer thereof bound to a molecule of interest. The peptides of the invention can be used, in particular, to vectorize via specific receptors (receptor-mediated transport, RMT), generally in the form of prodrug conjugates, molecules of pharmaceutical or diagnostic interest such as, for example, therapeutic molecules, imaging or diagnostic agents, or molecular probes, across cell membranes of different tissues or organs (such as liver, adrenal gland and intestine), healthy or pathologic (cancer cells), and in particular to enable their transport across physiological barriers of the nervous system such as the Blood brain barrier (BBB), Blood-spinal cord barrier (BSCB), or Blood-retinal barrier (BRB). |
| priorityDate | 2012-10-19^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 289 of 289.